文献速递糖尿病

48个月闭环胰岛素输注对新诊断1型糖尿病青少年残余C肽分泌及血糖控制的影响:一项随机试验

Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial.
PubMed 文献 · Diabetes Care · 2024-01-01

这项多中心随机平行试验的扩展阶段纳入96例新诊断1型糖尿病青少年(10至16.9岁),比较混合闭环(CL)与标准胰岛素治疗至诊断后48个月。48个月时两组空腹C肽经空腹血糖校正后无差异,但CL组中心实验室HbA1c低0.9%,目标范围内时间高12个百分点。

要点

  • 48个月时CL组与对照组空腹C肽经空腹血糖校正后无差异(平均校正差-2 pmol/L每mmol/L)。
  • CL组中心实验室HbA1c较对照组低0.9%(10 mmol/mol),差异有统计学意义。
  • CL组3.9至10.0 mmol/L目标范围内时间较对照组高12个百分点。

核心结论

  • 在1型糖尿病青少年中,与标准治疗相比,闭环胰岛素输注在诊断后48个月内持续改善血糖控制。
  • 闭环胰岛素输注对残余C肽分泌未见保护作用。

研究设计与样本

  • 多中心、随机、平行试验的24个月主要阶段后进入扩展阶段,按随机分组继续治疗至诊断后48个月。
  • 共96例新诊断1型糖尿病青少年,年龄10至16.9岁。
  • 扩展阶段有81例参与者继续(平均±标准差年龄14±2岁;闭环组47例,对照组34例)。
  • 闭环组使用基于Cambridge算法的混合闭环胰岛素输注,对照组为标准胰岛素治疗。
  • 分析采用意向性治疗。

主要发现

  • 48个月时空腹C肽经空腹血糖校正后两组无差异:闭环组5±9 vs 对照组6±14 pmol/L每mmol/L,平均校正差-2(95%CI -7至4;P=0.54)。
  • 中心实验室HbA1c闭环组较对照组低0.9%(10 mmol/mol;95%CI 0.2至1.5;3至17 mmol/mol;P=0.009)。
  • 3.9至10.0 mmol/L目标范围内时间闭环组较对照组高12个百分点(95%CI 3至20;P=0.008)。
  • 扩展阶段发生11例严重低血糖事件(闭环组6例,对照组5例)和7例糖尿病酮症酸中毒事件(闭环组3例,对照组4例)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We evaluated the effect of long-term intensive metabolic control with hybrid closed-loop (CL) on residual C-peptide secretion and glucose control compared with standard insulin therapy in youth with type 1 diabetes over 48 months. RESEARCH DESIGN AND METHODS: Following the 24-month primary phase of a multicenter, randomized, parallel trial of 96 newly diagnosed youth aged 10 to 16.9 years, participants were invited to an extension phase using treatment allocated at randomization. They continued with hybrid CL using the Cambridge algorithm or standard insulin therapy (control) until 48 months after diagnosis. Analysis was by intention-to-treat. RESULTS: At 24 months after diagnosis, 81 participants (mean ± SD age 14 ± 2 years) continued in the extension phase (47 CL, 34 control). There was no difference in fasting C-peptide corrected for fasting glucose at 48 months between groups (CL: 5 ± 9 vs. control: 6 ± 14 pmol/L per mmol/L; mean adjusted difference -2 [95% CI -7, 4; P = 0.54]). Central laboratory HbA1c remained lower in the CL group by 0.9% (10 mmol/mol [95% CI 0.2, 1.5; 3, 17 mmol/mol); P = 0.009). Time in target range of 3.9 to 10.0 mmol/L was 12 percentage points (95% CI 3, 20; P = 0.008) higher in the CL group compared with control. There were 11 severe hypoglycemic events (6 CL, 5 control) and 7 diabetic ketoacidosis events (3 CL, 4 control) during the extension phase. CONCLUSIONS: Improved glycemic control was sustained over 48 months after diagnosis with CL insulin delivery compared with standard therapy in youth with type 1 diabetes. This did not appear to confer a protective effect on residual C-peptide secretion.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ware J, Boughton CK, Allen JM, et al. Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial. Diabetes Care. 2024. PMID: 38924772. doi:10.2337/dc24-0360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。